SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs - Quaterly Results

13 May 2024 Evaluate
The revenue for the March 2024 quarter is pegged at Rs. 4148.20 millions, about 10.83% up against Rs. 3742.70 millions recorded during the year-ago period.Profit for the quarter ended March 2024 rises by 57.59% to Rs. 630.20  millions from Rs. 399.90 millions.Operating profit surged to 1130.20 millions from the corresponding previous quarter of 768.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 4148.20 3742.70 10.83 15021.30 15112.50 -0.60 15021.30 15112.50 -0.60
Other Income 56.80 0.00 0.00 110.10 12.80 760.16 110.10 12.80 760.16
PBIDT 1130.20 768.00 47.16 3571.60 3096.20 15.35 3571.60 3096.20 15.35
Interest 44.20 58.00 -23.79 166.30 204.90 -18.84 166.30 204.90 -18.84
PBDT 1086.00 710.00 52.96 3405.30 2891.30 17.78 3405.30 2891.30 17.78
Depreciation 173.20 142.50 21.54 660.10 557.70 18.36 660.10 557.70 18.36
PBT 912.80 567.50 60.85 2745.20 2333.60 17.64 2745.20 2333.60 17.64
TAX 282.60 167.60 68.62 738.70 616.30 19.86 738.70 616.30 19.86
Deferred Tax 165.60 27.60 500.00 278.10 95.00 192.74 278.10 95.00 192.74
PAT 630.20 399.90 57.59 2006.50 1717.30 16.84 2006.50 1717.30 16.84
Equity 453.10 453.10 0.00 453.10 453.10 0.00 453.10 453.10 0.00
PBIDTM(%) 27.25 20.52 32.78 23.78 20.49 16.05 23.78 20.49 16.05

Aarti Pharmalabs Share Price

696.60 -2.85 (-0.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×